A cross-sectional study assessing Pro-VC-Be short-form questionnaire in Canada; measuring psychosocial determinants of vaccination behavior in Canadian healthcare professionals
Vaccine hesitancy poses a significant challenge to worldwide public health and has been exacerbated by the COVID-19 pandemic, leading to heightened polarization and the spread of misinformation. Addressing vaccine hesitancy requires multifaceted strategies in which healthcare professionals (HCPs) play a critical role. Nonetheless, HCPs may also be hesitant toward vaccination. The 31-item original Pro-VC-Be tool, designed to measure the psychosocial determinants of vaccine attitudes in HCPs, was first validated in France, French-speaking Belgian regions, and Quebec (Canada). The validity of a short-form version was evaluated and found to be comparable to that of the long-form. Given differing vaccination recommendations and the changing pandemic context, assessing the tool's stability among diverse Canadian HCPs is crucial. Relying on the original short version of the Pro-VC-Be tool, a cross-sectional online survey was conducted among various Canadian HCPs (<i>N</i> = 544) to explore the psychosocial determinants that impact vaccination-related behaviors (frequency of general vaccination activity, vaccine recommendations activity, and willingness to recommend vaccines). The findings underscore three crucial dimensions - vaccine confidence, proactive efficacy, and trust in authorities - as robust predictors of positive professional practice and attitudes, and thus globally support the results obtained in previous studies using the Pro-VC-Be tool. HCPs with higher vaccine confidence, high proactive efficacy, and higher trust in authorities were 80% and 180% more likely to recommend vaccines to their patients and 80% more likely to have received a COVID-19 vaccine than other HCPs, respectively. By identifying the root causes of vaccine hesitancy among HCPs, adapted strategies can be developed.
Authors
- Catherine Pelletier (ORCID: https://orcid.org/0000-0003-3323-4244)
- Arnaud Gagneur (ORCID: https://orcid.org/0000-0002-2119-2799)
- Marie-Ève Trottier (ORCID: https://orcid.org/0000-0002-8188-9547)
- Ève Dubé (ORCID: https://orcid.org/0000-0003-1336-1510)
- Marina Rousseau
- Samuel Lemaire‐Paquette
- Pierre Verger (ORCID: https://orcid.org/0000-0002-0339-0679)
- David J. Roy
Institutions
- Université de Sherbrooke (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Southeastern Health (US)
- Université Laval (CA)
Publication Details
- Journal
- Human Vaccines & Immunotherapeutics
- Published
- 2025-05-04
- DOI
- https://doi.org/10.1080/21645515.2025.2499345
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Horizon 2020 Framework Programme